Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1226616 · FYE Dec 31 · Prices AT CLOSE 2026-07-30 (USD) — end-of-day, never a live or intraday quote
Last $1.34Day +3.88%Mkt cap $66M1Y −0.7%Off 52W high −31.6%Vol (1Y) 64.5%
Daily closing price, split-adjusted to the current basis; 3y shown of 4,936 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest0.6% of sh out |
| Days to cover4.3d |
| 13F net flow (QoQ)+0.07% |
| Top-10 13F concentration86.1% |
| Next report (est.)2026-08-14 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)$409,657 |
| Earnings (TTM)-$11.7M |
| ROE−25.5% |
| Net margin−2928.8% |
| ROIC−91.6% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD+2.3% |
| 1Y−0.7% |
| 3Y−43.7% |
| 5Y−63.1% |
| 10Y−78.6% |
| Since incept. (ann.)−10.6% |
Total return through 2026-07-30 · series begins 2006-12-08. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)64.5% |
| Ann. volatility (3Y)66.1% |
| Sharpe (1Y)0.31 |
| Sharpe (3Y)0.01 |
| Max drawdown (1Y)−34.6% |
| Max drawdown (3Y)−54.3% |
| Beta (3Y vs SPY)0.94 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| Essex Woodlands Management, Inc. | 1.1M | $2M | 2.25% | +0.0% |
| BlackRock, Inc. | 705,954 | $967,157 | 1.43% | +0.1% |
| CITIGROUP INC | 635,715 | $870,929 | 1.29% | +0.0% |
| VANGUARD CAPITAL MANAGEMENT LLC | 611,039 | $837,123 | 1.24% | new |
| GEODE CAPITAL MANAGEMENT, LLC | 543,843 | $745,254 | 1.10% | +2.7% |
| VANGUARD FIDUCIARY TRUST CO | 280,621 | $384,451 | 0.57% | new |
| UBS Group AG | 222,200 | $304,414 | 0.45% | −1.5% |
| STATE STREET CORP | 193,698 | $265,366 | 0.39% | +0.0% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-14 | −$0.05 | — | $186,984 | — |
| 2025-09-30 | 2025-11-12 | −$0.06 | — | $123,319 | — |
| 2025-06-30 | 2025-08-14 | −$0.07 | — | $134,599 | — |
| 2025-03-31 | 2025-05-13 | −$0.06 | — | — | — |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-14 is ESTIMATED from filing cadence (median gap 92d) — not company-confirmed.
